Publications by authors named "Hyera Kim"

Objective: To analyze crude protein, crude fat, crude ash, crude fiber, amino acids, fatty acids, and minerals in insect-based dog foods and to evaluate their compliance with nutritional guidelines.

Methods: Proximate analysis, mineral analysis, amino acid profiling, and fatty acid composition analysis were conducted from November 27, 2023, through February 2024 on 18 commercially available insect-based dog foods formulated for all-life-stage or adult dogs.

Results: Proximate analysis results revealed that all 18 pet foods met the Association of American Feed Control Officials guidelines.

View Article and Find Full Text PDF
Article Synopsis
  • The study focuses on using DNA damage repair (DDR) gene mutations as potential biomarkers to predict the effectiveness of immune checkpoint inhibitors (ICIs) in patients with advanced non-small cell lung cancer (NSCLC).
  • Researchers analyzed data from 55 NSCLC patients, finding that those with two or more DDR mutations (termed DDR2 positive) had significantly better outcomes compared to those without these mutations, particularly in patients with low PD-L1 expression.
  • The results suggest that combining assessments of DDR mutations and PD-L1 expression can enhance the prediction of patient responses to ICIs, leading to more personalized and effective treatment strategies.
View Article and Find Full Text PDF

Introduction: Current standard chemotherapy for biliary tract cancer (BTC) has limited survival benefits, and the need for targeted therapies is increasing. This study investigated the genetic profiles and clinical implications of BRCA mutations in patients with advanced BTC.

Methods: Targeted high-throughput sequencing was performed on samples obtained from 25 patients with advanced BTC who had received palliative first-line platinum-based chemotherapy.

View Article and Find Full Text PDF

Background: Elderly patients with extensive-disease small-cell lung cancer (ED-SCLC) have a high risk of chemotherapy toxicity due to multiple comorbidities and poor performance status. Although dose modification is often used to avoid toxicity in elderly patients with ED-SCLC, there is little data on the effect of initial dose-reduced chemotherapy on survival outcomes.

Methods And Patients: We retrospectively reviewed 100 elderly patients (≥70 years) with ED-SCLC who received first-line etoposide plus platinum chemotherapy between January 2006 and December 2020.

View Article and Find Full Text PDF

Background: Biliary tract cancer (BTC) is associated with poor prognosis because of its aggressive and heterogeneous nature. Programmed death ligand 1 (PD-L1) has been considered a novel biomarker for prognosis and response of immune checkpoint inhibitors in various tumors. However, there are limited data reporting on the role of PD-L1 in advanced BTC patients.

View Article and Find Full Text PDF

Background/aim: Biliary tract cancer (BTC) has a poor prognosis due to its highly invasive and metastatic potential. Ataxia-telangiectasia mutated (ATM) is a key regulator of DNA damage response and an emerging therapeutic target; however, the association between the expression of ATM and the prognosis in advanced BTC is unknown. We aimed to identify the relationship between ATM expression, clinicopathological characteristics, and survival outcomes in patients with advanced BTC.

View Article and Find Full Text PDF

Purpose: To assess the efficacy and safety of docetaxel rechallenge in the salvage setting in metastatic castration-resistant prostate cancer (mCRPC) patients.

Materials And Methods: Clinicopathologic data from patients treated with docetaxel rechallenge were collected from a single-center cancer registry. Among 227 patients who received first-line docetaxel for mCRPC between January 2011 and June 2019, 23 undergo rechallenge docetaxel after failure to androgen receptor targeting agents and/or cabazitaxel treatment.

View Article and Find Full Text PDF
Article Synopsis
  • Anti-PD1 inhibitors like pembrolizumab and nivolumab are approved for recurrent or metastatic head and neck cancer (HNC), but their effectiveness in broader patient populations remains unclear.
  • A study of 46 patients receiving these treatments found that those with head and neck squamous cell carcinoma (HNSCC) had a median progression-free survival of 3.7 months and an overall survival of 6.8 months, while nasopharyngeal cancer (NPC) patients had slightly better outcomes.
  • The results indicated a 21% objective response rate overall, with better survival in patients previously treated with radiotherapy and those treated with pembrolizumab compared to nivolumab.
View Article and Find Full Text PDF
Article Synopsis
  • Non-anthracycline chemotherapy, particularly with l-asparaginase, has improved survival rates in ENKTL patients, leading to changes in the rates of CNS relapse when compared to earlier findings.
  • A study involving 399 and 253 patients reviewed the impact of intermediate-dose methotrexate (ID-MTX) on CNS relapse, developing a CNS prognostic index (CNS-PINK) that identifies high-risk individuals.
  • Results showed that patients classified as high-risk CNS-PINK had a different cumulative incidence of CNS relapse based on treatment, with those receiving ID-MTX displaying lower rates, indicating potential benefits that should be explored further in future research.
View Article and Find Full Text PDF

We investigated the size-based isolation and enumeration of circulating tumor cells (CTCs) using a centrifugal microfluidic device equipped with a fluid-assisted separation technology (FAST) disc. We further assessed the correlations among CTCs, cancer antigen-125 (CA125) levels, and clinical course of the disease in a prospective analysis of 47 serial blood samples collected at multiple time-points from 13 ovarian cancer patients. CTCs were isolated from whole blood using the FAST disc and were classified as epithelial cell adhesion molecule (EpCAM)/cytokeratin+, CD45-, and 4',6-diamidino-2-phenylindole (DAPI)+.

View Article and Find Full Text PDF
Article Synopsis
  • No approved targeted therapies exist for bladder cancer, prompting researchers to investigate the effects of single and combination therapies on cancer cells using a high-throughput screening platform.
  • The study tested 24 targeted agents on seven human bladder cancer cell lines, identifying that the effectiveness of these agents varied based on the specific genomic alterations present in the cancer cells.
  • Notably, the combination therapies showed enhanced antitumor effects compared to single agents, indicating potential for better treatment outcomes using a 3D culture-based approach.
View Article and Find Full Text PDF

Background: A taxane plus ramucirumab as second-line therapy followed by a checkpoint inhibitor (CPI) in third line has become a standard treatment strategy for advanced gastric cancer.

Objective: Herein, we investigated the impact of prior ramucirumab use on the efficacy of third-line immunotherapy and performed an exploratory analysis to identify potential biomarkers for the success of immunotherapy.

Patients And Methods: We retrospectively analyzed patients receiving CPI as a third-line treatment for advanced gastric cancer between January 2015 and March 2019.

View Article and Find Full Text PDF

Background: Biliary tract cancers (BTC) have a poor prognosis even after curative resection because of frequent local and distant recurrences. Therefore, the importance of adjuvant therapy in BTC has been advocated to improve outcomes. However, the choice of adjuvant therapy is still controversial.

View Article and Find Full Text PDF

Background/aims: The occurrence of brain metastasis (BM) has increased due to improved overall survival (OS) in uterine cervical cancer. However, research about prognostic factors and therapeutic guidelines for BM in uterine cervical cancer remains scarce due to the rarity of BM in this type of cancer. The present study evaluated the clinical characteristics and prognostic factors influencing OS in patients with BM from uterine cervical cancer.

View Article and Find Full Text PDF

Background: Although organizing pneumonia (OP) responds well to corticosteroid therapy, relapse is common during dose reduction or follow-up. Predictors of relapse in OP patients remain to be established. The aim of the present study was to identify factors related to relapse in OP patients.

View Article and Find Full Text PDF

Background: Bronchial anthracofibrosis (BAF), which is associated with exposure to biomass smoke in inefficiently ventilated indoor areas, can take the form of obstructive lung disease. Patients with BAF can mimic or present with an exacerbation of chronic obstructive pulmonary disease (COPD). The purpose of the current study was to investigate the prevalence of BAF in Korean patients with COPD exacerbation as well as to examine the clinical features of these patients in order to determine its clinical relevance.

View Article and Find Full Text PDF

A patient treated with venlafaxine for major depression developed an interstitial lung disease (ILD) with the characteristic clinical, radiological and pathological features of chronic hypersensitivity pneumonitis. A high resolution computed tomography scan demonstrated ground glass opacity, mosaic perfusion with air-trapping and traction bronchiectasis in both lungs. The pathological findings were consistent with a nonspecific interstitial pneumonia pattern.

View Article and Find Full Text PDF

A PHP Error was encountered

Severity: Warning

Message: fopen(/var/lib/php/sessions/ci_session8trca7rp5g96aasaog208ges3kb677fd): Failed to open stream: No space left on device

Filename: drivers/Session_files_driver.php

Line Number: 177

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once

A PHP Error was encountered

Severity: Warning

Message: session_start(): Failed to read session data: user (path: /var/lib/php/sessions)

Filename: Session/Session.php

Line Number: 137

Backtrace:

File: /var/www/html/index.php
Line: 316
Function: require_once